<DOC>
	<DOCNO>NCT00371579</DOCNO>
	<brief_summary>Objective : Determine maximum dos rosuvastatin safe patient infect hepatitis C call pleiotropic effect rosuvastatin cause decrease HCV viral load . Primary study parameter : 1. extend cause rosuvastatin serious side effect like rhabdomyolysis hepatotoxicity patient chronically infect hepatitis C ? 2. treatment rosuvastatin HCV infect patient lead low HCV-RNA viral load ? 3 . Is decrease LDL correlate decrease HCV-RNA load ?</brief_summary>
	<brief_title>Rosuvastatin Hepatitis C</brief_title>
	<detailed_description>Study design : 's pilot study patient form control group . A total 10 patient include . To evaluate effect maximum dos rosuvastatin liver function side effect , first 2 patient treat evaluate . If experience serious adverse event 8 patient include . The dose rosuvastatin increase period 4 week . Intervention : base experience treat dyslipidemia , gradually increase dose rosuvastatin diminishes experience side effect decrease chance develop hepatotoxicity . Therefore study choose increase dose ( see flowchart ) . Patients start 5 mg day wich increase 1 week 10 mg per day . After second week therapy increase 20 mg per day execute . This dose give another 2 week . At week 4 treatment increase 40 mg do .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>age 18 65 year All patient hepatitis C ( genotype ) negative hepatitis B HIV ALAT &lt; 2,5 x upper limit normal serological evidence hepatitis C infection detectable HCVRNA ( Bayer Versant HCV bDNA V3.0 ) fail current standard care treatment peginterferon ribavirin WHOscore ≤1 fertile woman must negative pregnancy test week start medication . Use contraceptives whole studyperiod physically mentally able attend outpatient clinic Hepatitis C patiënts naive ( peg ) interferon ribavirin treatment Alcohol abuse ( &gt; 20 gram per day ) last year liver cirrhosis detect liver biopsy decompensated liver disease ( childpugh B C ) concomitant treatment hepatotoxic medication / interfere CYP450 system : antifungal medication ( voriconazole ) , antibiotic ( gentamycine , azitromycine , claritromycin , erytromycin ) , immuunsuppresive drug ( cyclosporine ) , antiarythmia ( diltiazem , verapamil ) tuberculostatic drug ( rifampicin ) . current statin use active pregnancy wish pregnangy use grapefruit juice mentally fit participate study daily use 2 gram paracetamol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>rosuvastatin</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>geranylgeranylation</keyword>
	<keyword>HCV-RNA load</keyword>
</DOC>